ImmunityBio
IBRX
IBRX
60 hedge funds and large institutions have $57.4M invested in ImmunityBio in 2017 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 16 increasing their positions, 22 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
33% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 9
38% less capital invested
Capital invested by funds: $92.1M → $57.4M (-$34.7M)
Holders
60
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$7.35M | |
| 2 | +$1.64M | |
| 3 | +$570K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$488K |
| 5 |
Barclays
London,
United Kingdom
|
+$295K |
Top Sellers
| 1 | -$1.49M | |
| 2 | -$631K | |
| 3 | -$378K | |
| 4 |
TI
Trexquant Investment
Stamford,
Connecticut
|
-$209K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$134K |